Berries Clinically Focused Pharmacogenetics (PGx) Test
$499.00
Berries Clinically Focused Pharmacogenetics (PGx) Test and Risk Assessment provides a comprehensive insight into genetic variations that can influence drug metabolism and effectiveness. This sophisticated test helps identify potential adverse drug reactions, drug intolerance, and dosage optimization in an effort to improve your treatment outcomes and overall health.
Detailed Information:
| Test | Genes | Diseases | Examples of Medication |
| Clinically Focused Pharmacogenomics(PGx) and Risk Assessment | APOE, BCHE, COMT, CYP1A2, CYP2B6, CYP2C19, CYP2C9, CYP2D6, CYP3A5, CYP4F2, F2, F5, MTHFR, SLCO1B1, VKORC1 | Oncology, Cardiovascular, Dermatology, Diabetes, Gastrointestinal, Endocrinology, Metabolism, Gynecology, Hematology, Infections, Pain, Psychotropic, Rheumatology, Sexual Wellness, Transplantation, Urology | Addyi, Atorvastain, Clozapine, Dexlansoprazole, Dexmethylphenidate, Dronabinol, Erdafitinib, Fentanyl, Fluvastatin, Lansoprazole, Methylphenidate, Olanzapine, Omeprazole, Pantoprazole, Siponimod, Tacrolimus, Tizanidine, Viagra, Warfarin, |
